Aura Biosciences Directors and Executives Sell Shares on February 17, 2026.
ByAinvest
Tuesday, Feb 17, 2026 7:53 pm ET1min read
AURA--
Aura Biosciences, Inc. announces that Elisabet de los Pinos, Director, President, and Chief Executive Officer, has sold 47,648 shares at $5.06 per share on February 17, 2026. Amy Elazzouzi, Senior Vice President of Finance, has also sold 8,549 shares at $5.06 per share on the same date. Janet Jill Hopkins, Chief Medical Officer, has sold 20,401 shares at $5.06 per share, while Conor Kilroy, Chief Legal Officer and Secretary, has sold 12,079 shares at $5.05 per share. Mark Plavsic, Chief Technology Officer, has sold 15,890 shares at $5.05 per share on February 17, 2026.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet